Pregled bibliografske jedinice broj: 1003695
Association of HLA alleles and haplotypes with endemic nephropathy in Croatia.
Association of HLA alleles and haplotypes with endemic nephropathy in Croatia. // HLA
Lisabon, Portugal, 2019. str. 395-396 doi:10.1111/tan.13518 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1003695 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Association of HLA alleles and haplotypes with endemic nephropathy in Croatia.
Autori
Dittrich, Damir ; Maskalan, Marija ; Kaštelan, Željko ; Žunec, Renata ; Grubić, Zorana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
HLA
/ - , 2019, 395-396
Skup
33rd European Immunogenetics and Histocompatibility Conference
Mjesto i datum
Lisabon, Portugal, 08.05.2019. - 11.05.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
HLA ; endemic nephropathy ; Croatia
Sažetak
Endemic nephropathy (EN) is a chronic kidney disease affecting populations in several countries, with an endemic focus in eastern Croatia with a population of about 10, 000 people. EN is a multifactorial disease with polygenic predis position to environmental risk agents. Recently, next generation sequencing nominated three genes tightly connected to process of angiogenesis as candidate genes for predispos tion to Balkan endemic nephropathy, one of them (KCNK5) being located on chromosome 6p21.2, in close proximity to the HLA region. Prompted by this finding, we investigated HLA-A, - B, and -DRB1 alleles and haplotypes in the popu lation of patients with EN (N=103) and matched healthy controls (N=190). All individuals were tested by PCR-SSO for low resolution typing and PCR-SSP to obtain a high- resolution typing. The results showed higher presence of HLA-DRB1*04:02 allele in EN (P=0.013, OR=3.006, 95% CI=1.28-7.07), in contrast to the lower frequency of HLA- A*01:01, B*57:01 and B*27:05 alleles (P=0.002, OR=0.373, 95% CI=0.19-0.72 ; P=0.032, OR=0.339, 95% CI=0.13-0.90 and P=0.006, OR=0.098, 95% CI=0.01-0.74, respectively). Moreover, when EN patient’s HLA haplotypes were compared to controls, two haplotypes were present with higher frequency within EN patient group, HLA- A*02:01~B*27:02~DRB1*16:01 and HLA- A*26:01~B* 38:01~DRB1*04:02 (P=0.002, OR=0 and P=0.054, OR=4.702, 95% CI=0.90-24.45, respectively) while HLA- A*02:01~B*57:01~DRB1*16:01 (P=0.031, OR=0) haplo- type showed a significantly lower frequency. HLA- A*02:01~B*27:05~DRB1*01:01 and HLA-A*01:01~B* 57:01~DRB1*07:01 haplotypes were also less frequent among EN patients but this difference did not reach statistical significance. In conclusion, our results point toward genetic susceptibility of EN and observed differences in both susceptible/protective HLA profiles indicate the necessity of further studies.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Opća bolnica "Dr. Josip Benčević",
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE